SCHEMBL2994617

SCHEMBL2994617

Cc1ccc2c(c1)c(C(=O)C(=O)NC1CCC1)c(Cl)n2Cc1ccc(Cl)cc1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 4/20 0.41
LMNA P02545 3/20 0.40
MAPT P10636 2/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
ALPL P05186 1/20 0.40
ALPI P09923 1/20 0.40
HPGD P15428 1/20 0.40
ALOX12 P18054 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
MDM2 Q00987 1/20 0.40
FAAH O00519 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
SIGMAR1 Q99720 1/20 0.39
EPHX2 P34913 1/20 0.38
SOS1 Q07889 1/20 0.37
CNR1 P21554 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2995566 0.98 CNR2 (0.43) CNR2LMNAMAPTMEN1ALDH1A1
SCHEMBL3007029 0.97 MAPT (0.44) CNR2LMNAMAPTMEN1ALDH1A1
SCHEMBL2995185 0.96 CNR2 (0.41) CNR2LMNAMAPTMEN1ALDH1A1
SCHEMBL3005711 0.93 LMNA (0.43) CNR2LMNAMAPTMEN1ALDH1A1
SCHEMBL2995773 0.91 ALDH1A1 (0.46) CNR2LMNAMAPTMEN1ALDH1A1
SCHEMBL2998712 0.91 ALDH1A1 (0.47) CNR2LMNAMAPTMEN1ALDH1A1
SCHEMBL3001079 0.90 MAPT (0.47) CNR2LMNAMAPTMEN1ALDH1A1
SCHEMBL2992509 0.90 L3MBTL1 (0.42) CNR2LMNAMAPTMEN1ALDH1A1
SCHEMBL2991069 0.89 SIGMAR1 (0.43) CNR2LMNAMAPTMEN1ALDH1A1
SCHEMBL3001317 0.89 MAPT (0.39) CNR2LMNAMAPTMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8884020-B2 Indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2014-11-11 US disclosed
EP-2610244-A1 Indole compounds Ironwood Pharmaceuticals, Inc. (US) 2013-07-03 EP disclosed
CN-102850324-A Indole compounds MICROBIA INC 2013-01-02 CN disclosed
US-20100197708-A1 INDOLE COMPOUNDS WELLS FARGO BANK, NATIONAL ASSOCIATION 2010-08-05 US disclosed
US-20090118503-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. 2009-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197708-A1 INDOLE COMPOUNDS IDO1, IDO2, TPH2 CNR2 20/4885LMNA 3450/4885MAPT 997/4885
US-20090118503-A1 FAAH INHIBITORS FAAH, FAAH2, CNR2 CNR2 3/4885LMNA 4089/4885MAPT 2737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.